(Q40933793)

English

High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.

scientific article published on June 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

vector-borne disease

0 references

author name string

Conway JE

1

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Rhys CM

2

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Zolotukhin I

3

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Zolotukhin S

4

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Muzyczka N

5

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Hayward GS

6

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Byrne BJ

7

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

publication date

1 June 1999

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

986-993

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Adeno-associated virus (AAV) vector antisense gene transfer in vivo decreases GABA(A) alpha1 containing receptors and increases inferior collicular seizure sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Adeno-associated virus vectors for gene therapy of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Mutagenesis of an AUG codon in the adeno-associated virus rep gene: effects on viral DNA replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Adeno-associated virus vectors can be efficiently produced without helper virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Cell lines for the production of recombinant adeno-associated virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Preclinical Testing of Recombinant Adenoviral Herpes Simplex Virus-Thymidine Kinase Gene Therapy for Central Nervous System Malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Adeno-associated virus DNA replication is induced by genes that are essential for HSV-1 DNA synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Properties of an adenovirus type 2 mutant, Ad2d/807, having a deletion near the right-hand genome terminus: Failure to help AAV replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Defective-interfering particles of the human parvovirus adeno-associated virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Adeno-Associated Virus RNA Transcription in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Inhibition of Cellular transformation by the adeno-associated virus rep gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

The intranuclear location of a herpes simplex virus DNA-binding protein is determined by the status of viral DNA replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

A herpesvirus regulatory protein appears to act post-transcriptionally by affecting mRNA processing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Preventive therapy for periodontal diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

21 January 2018

Role for highly regulated rep gene expression in adeno-associated virus vector production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

7 January 2021

based on heuristic

inferred from DOI database lookup

A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

7 January 2021

based on heuristic

inferred from DOI database lookup

Herpes simplex virus IE63 acts at the posttranscriptional level to stimulate viral mRNA 3' processing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300937

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3300937

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40933793&oldid=2204107696"